A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

  1. Primo, D.
  2. Scarfò, L.
  3. Xochelli, A.
  4. Mattsson, M.
  5. Ranghetti, P.
  6. Espinosa, A.B.
  7. Robles, A.
  8. Gorrochategui, J.
  9. Martínez-López, J.M.
  10. de la Serna, J.
  11. González, M.
  12. Gil, A.C.
  13. Anguita, E.
  14. Iraheta, S.
  15. Munugalavadla, V.
  16. Quéva, C.
  17. Tannheimer, S.
  18. Rosenquist, R.
  19. Stamatopoulos, K.
  20. Ballesteros, J.
  21. Ghia, P.
Aldizkaria:
Oncotarget

ISSN: 1949-2553

Argitalpen urtea: 2018

Alea: 9

Zenbakia: 40

Orrialdeak: 26019-26031

Mota: Artikulua

DOI: 10.18632/ONCOTARGET.25419 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus